Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eurasian J Med ; 40(2): 91-3, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25610037

RESUMO

Apert syndrome is a type of acrocephalosyndactilia that consists of craniofacial synostosis, midface hypoplasia and syndactyly, with an autosomal dominant inheritance pattern. During anesthesia, difficult intubation and ventilation may be observed because of abnormal airways. In one of our patients, visceral anomalies, such as esophageal stricture and post-strictural dilatation, may cause respiratory problems because of aspiration. The second case was a Mallampati grade 2 with craniofacial synostoses, midface hypoplasia and syndactyly. In the case of apert syndrome, anesthetists must be prepared for intubation difficulties, airway and ventilation problems and even visceral anomalies.

2.
Auris Nasus Larynx ; 29(3): 253-6, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12167446

RESUMO

The objective was to assess the antiemetic activity of granisetron, dexamethasone and droperidol in the otologic surgeries. Sixty patients in ASA (American Society of Anesthesiologists) I and II risk groups who underwent surgery for chronic otitis media were assessed in a double blind and randomized trial. The patients were divided into three equal groups. Single intravenous dose of granisetron (3 mg), granisetron (3 mg) plus dexamethasone (8 mg) and droperidol (1.25 mg) were prophylactically administered to the patients in group 1, group 2 and group 3, respectively, and their antiemetic actions were compared. The antiemetic effects of the drugs were not significantly different between the groups (P>0.05). The antiemetic effects also did not differ significantly in the early and late postoperative periods (P>0.05). In conclusion, the results of prophylactic use or side effects of granisetron, granisetron plus dexamethasone or droperidol are similar in middle ear surgery. Therefore, cost effectivity of the antiemetic prophylaxis should be reconsidered in otologic surgery in the light of the results of this study.


Assuntos
Antieméticos/uso terapêutico , Dexametasona/uso terapêutico , Droperidol/uso terapêutico , Granisetron/uso terapêutico , Otite Média/cirurgia , Náusea e Vômito Pós-Operatórios/tratamento farmacológico , Adulto , Antieméticos/efeitos adversos , Doença Crônica , Dexametasona/efeitos adversos , Método Duplo-Cego , Droperidol/efeitos adversos , Quimioterapia Combinada , Feminino , Granisetron/efeitos adversos , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA